Executive Changes

Along with its 2024 full-year and fourth-quarter results – both down slightly – the Los Angeles-based firm on 19 February announced its board appointed Stephan Gratziani, president since January 2024, as CEO effective 1 May.

Cosette Pharmaceuticals has made two key executive appointments as it looks to build up its business. Meanwhile, Canada’s CGPA has named a chair and vice-chair, and Chanelle and Neuraxpharm have announced their own executive changes.

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

As Sandoz’s north American president Keren Haruvi gears up for a second term as chair of US generics and biosimilars association the AAM, other firms – including Sunshine Biopharma, Centrient and Rosemont – have also announced executive appointments.

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

NutriFusion adds development, innovation head; Dymatize adds tennis pro, Olympic medalist Tommy Paul to Squad; Icy Hot sponsors Unrivaled women’s hoops league; WNBA’s Stevens, Evans invest in, promote Mela Vitamins.

Medicines for Europe names a new president, the IGBA reveals its latest chair, and Chanelle and Xbrane announce fresh faces in key roles, in our latest round-up of off-patent industry appointments.

Stada has made the strongest indication yet that it is preparing for an initial public offering, appointing Andreas Fibig as independent chairman of a board of directors that will be established “in the event of an IPO.”